Microprocessor knees (MPKs) have been available on the NHS for established prosthetic users since April, 2017. Observations at our centre in an established cohort saw patients decreasing risk of falls and improving energy expenditure, alongside other physical and psychological benefits. This raised the question of whether MPKs should be considered for new post-amputation patients who also meet the NHS inclusion criteria (Clinical Commissioning Policy, 2016).
My poster aims to review one service’s experience with prescribing MPK’s to patients as their first prosthetic prescription to determine what selection criteria might ensure successful MPK use at 12 months.